When was Alchemy Pharmatech founded?

Alchemy Pharmatech was founded in 2012 and raised its 1st funding round within a year of its incorporation.

Where is Alchemy Pharmatech located?

Alchemy Pharmatech is headquartered in Runcorn, United Kingdom.

Who is the current CEO of Alchemy Pharmatech?

Robert Clayborough of Alchemy Pharmatech.

Which legal entities is Alchemy Pharmatech associated with?

Alchemy Pharmatech is associated with ALCHEMY PHARMATECH LIMITED.

How many employees does Alchemy Pharmatech have?

As of Jul 31, 2026, the latest employee count at Alchemy Pharmatech is 5.

Is Alchemy Pharmatech a funded company?

Alchemy Pharmatech is a funded company, having raised a total of $861K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 11, 2012.

When was the latest funding round of Alchemy Pharmatech?

Alchemy Pharmatech's latest funding was a $***** Seed round on May 05, 2015, with participation from 1 investor. Its primary sector is Drug Delivery. Globally, the Drug Delivery sector has seen $511M in funding in 2026 to date.

Where does Alchemy Pharmatech rank among its competitors?

Alchemy Pharmatech ranks 276th amongst 1204 active competitors, of which 102 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Arecor, which secured $8.26M in Jul, 2024.

Who are the top competitors of Alchemy Pharmatech?

Alchemy Pharmatech's top competitors include WuXi AppTec, Precision Medicine Group and ANI Pharmaceuticals. Among them, Arecor secured the most recent funding round in July, 2024.

Alchemy Pharmatech - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Alchemy Pharmatech formerly called Alchemy Healthcare develops drug delivery platforms in partnership with the pharmaceutical industry. It currently has a technology platform to aerosolise dry powder medicines to provide unit-dose, needle-free intranasal delivery. The platform originally developed for drug powder formulations can also be used for peptide biologicals or vaccines. Its technology is claimed to be easy to use and is an ideal method for paediatric delivery.

Key Metrics

Founded Year

2012

Location

Runcorn, United Kingdom

Stage

Seed

Total Funding

$861K in 2 rounds

Latest Funding Round

Seed, May 05, 2015, $*****

Investors

Northwest Fund & 6 more

Ranked

276^th among 1204 active competitors

Employee Count

5 as on Jul 31, 2026

Similar Companies

Avadel Pharmaceuticals & 134 more

View Alchemy Pharmatech's full profile

Alchemy Pharmatech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ALCHEMY PHARMATECH LIMITED CIN: 7912825 , Germany, Active	Jan 16, 2012	-	2 (As on Mar 31, 2021)

Alchemy Pharmatech has raised a total funding of $861K over 2 rounds. Its first funding round was on Jun 11, 2012. Its latest funding round was a Seed round on May 05, 2015 for $*****. 1 investor participated in its latest round. Alchemy Pharmatech has 3 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Alchemy Pharmatech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 05, 2015	6437951	Seed	1610866	5452859	1184384	5224298
Jun 11, 2012	1297454	Seed	9992741	6494952	1449387	Spark Impact

Access funding benchmarks and valuations. Sign up today!

View details of Alchemy Pharmatech's funding rounds and investors

Alchemy Pharmatech's employee count trend

Alchemy Pharmatech has 5 employees as of Jul 26. Here is Alchemy Pharmatech's employee count trend over the years:

Employee count trend for Alchemy Pharmatech

Uncover Alchemy Pharmatech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alchemy Pharmatech include WuXi AppTec, Precision Medicine Group and ANI Pharmaceuticals. Here is the list of Top 10 competitors of Alchemy Pharmatech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	75/100
2nd	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Oak Investment Partners & 7 others	72/100
3rd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorgan Chase, Ampersand Capital & 4 others	64/100
4th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, PAI Partners & 2 others	63/100
5th	Avadel Pharmaceuticals 1990, Dublin (Ireland), Acquired	Pharma company with proprietary drug delivery tools and drug for narcolepsy	-	Venrock, RTW Investments & 4 others	61/100
6th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
7th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
8th	Arecor 2007, Cambridge (United Kingdom), Public	Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery	$8M	Downing, Calculus Capital & 9 others	58/100
9th	PharmaJet 2005, Golden (United States), Series B	Provider of needle-free injection technology	$59.4M	Plug and Play Tech Center, Rockies Venture Club ... & 12 others	58/100
10th	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, Pantheon International ... & 3 others	57/100
276th	Alchemy Pharmatech 2012, Runcorn (United Kingdom), Seed	Develops drug delivery platforms with focus in non-invasive intranasal delivery	$861K	Northwest Fund, Spark Impact & 5 others	27/100